Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Hormone Booster” Firms To Pay Largest Ever FTC Health Fraud Settlement

This article was originally published in The Tan Sheet

Executive Summary

Marketers of products deceptively claiming to increase human growth hormone (HGH) levels are required to pay up to $20 mil. in consumer redress under a settlement, the Federal Trade Commission announced June 9

Marketers of products deceptively claiming to increase human growth hormone (HGH) levels are required to pay up to $20 mil. in consumer redress under a settlement, the Federal Trade Commission announced June 9.

Destin, Fla.-based corporations Great American Products and Physician's Choice and related defendants will immediately pay $6.5 mil. into a consumer redress program set up by the commission. The defendants could be required to pay up to $13.5 mil. more depending upon consumer redress requests.

The sum represents the largest judgment ever obtained in an FTC health fraud case, the agency said.

The settlement also includes an "avalanche clause," bringing the liability up to $80 mil. in the event defendants misrepresented their financial situation.

Dietary supplements and sprays marketed under brands such as Ultimate HGH, Super HGH Booster, Master HGH and Super HGH carried false claims they boosted HGH levels, FTC alleged in a complaint filed May 10 in Northern Florida federal court.

Promotional materials for the products carried claims of "reduced fat, cholesterol and blood pressure, increased muscle mass and improved cognitive, immune and sexual function," FTC said.

The complaint also challenged claims for other products, including Fat Blaster, Super Carbo Blocker and Wild Oregano Oil products, and alleged violations of the Telemarketing Sales Rule.

Defendants are barred under the agreement from making unsubstantiated claims for their products, misrepresenting test results and violating the TSR.

The case was originally referred to the FTC by infomercial watchdog Electronic Retailing Self-Regulation Program, a division of the National Advertising Review Council, in September 2004 (1 'The Tan Sheet' Sept. 20, 2004, In Brief).

The trade commission is ramping up enforcement of false HGH product claims. In a same-day announcement, the agency stated it recently has issued letters to more than 90 Internet-based HGH marketers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel